Shamima Afrin Ruma

Novel glycovariant biomarkers of CA125 and CA15-3 and their diagnostic performance across histotypes of ovarian cancer: A multi-cohort study in Sweden and Finland (2025)

European Journal of Obstetrics and Gynecology and Reproductive Biology

Roos Alexander, Hanna; Jain, Shruti; Gidwani, Kamlesh; Ulfenborg, Benjamin; Ottander, Ulrika; Lundin, Eva; Hynninen, Johanna; Afrin Ruma, Shamima; Huhtinen, Kaisa; Sundfeldt, Karin; Pettersson, Kim; Idahl, Annika

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

MUC1 and glycan probing of CA19-9 captured biomarkers from cyst fluids and serum provides enhanced recognition of ovarian cancer (2025)

Scientific Reports

Afrin Ruma, Shamima; Vinod, Rufus; Jain, Shruti; Huhtinen, Kaisa; Hynninen, Johanna; Leivo, Janne; Pettersson, Kim; Sundfeldt, Karin; Gidwani, Kamlesh

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Aberrant glycosylation of α3 integrins as diagnostic markers in epithelial ovarian cancer (2023)

Clinica Chimica Acta

Jain Shruti, Parimelazhagan Santhi Priyadharshini, Vinod Rufus, Afrin Ruma Shamima, Huhtinen Kaisa, Pettersson Kim, Sundfeldt Karin, Leivo Janne, Gidwani Kamlesh

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer (2022)

International Journal of Cancer

Jain Shruti, Nadeem Nimrah, Ulfenborg Benjamin, Mäkelä Maria, Ruma Shamima Afrin, Terävä Joonas, Huhtinen Kaisa, Leivo Janne, Kristjansdottir Björg, Pettersson Kim, Sundfeldt Karin, Gidwani Kamlesh

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Shamima

Afrin Ruma

Ota yhteyttä

Julkaisut

Järjestä:

Novel glycovariant biomarkers of CA125 and CA15-3 and their diagnostic performance across histotypes of ovarian cancer: A multi-cohort study in Sweden and Finland (2025)

MUC1 and glycan probing of CA19-9 captured biomarkers from cyst fluids and serum provides enhanced recognition of ovarian cancer (2025)

Aberrant glycosylation of α3 integrins as diagnostic markers in epithelial ovarian cancer (2023)

Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer (2022)